Related Experiment Video

Updated: Jun 13, 2026

Exploring the Sequential Cellular Events of Phagocytosis Triggered by Godanti Bhasma in Mammalian Cells
10:10

Exploring the Sequential Cellular Events of Phagocytosis Triggered by Godanti Bhasma in Mammalian Cells

Published on: July 11, 2025

Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol

Yvonne Maria te Welscher1, Lynden Jones, Martin Richard van Leeuwen

  • 1Department of Biochemistry of Membranes, Bijvoet Center, Institute of Biomembranes, Utrecht University, Utrecht CH, The Netherlands. y.m.tewelscher@uu.nl

Antimicrobial Agents and Chemotherapy
|April 14, 2010
PubMed

Insights

The antifungal antibiotic natamycin inhibits vacuole membrane fusion by interfering with ergosterol-dependent priming. This novel mechanism, distinct from membrane disruption, suggests broader effects on ergosterol-dependent cellular processes.

Area of Science:

  • * Molecular Biology
  • * Cell Biology
  • * Mycology

Background:

  • * Natamycin is a polyene antifungal antibiotic that interacts with ergosterol in cell membranes.
  • * Unlike other polyenes (e.g., nystatin), natamycin does not disrupt membrane barrier function.
  • * Vacuole membrane fusion is a critical cellular process dependent on ergosterol.

Purpose of the Study:

  • * To investigate the effect of natamycin on ergosterol-dependent vacuole membrane fusion.
  • * To elucidate the specific mechanism by which natamycin impacts membrane fusion.
  • * To determine if natamycin's activity is linked to ergosterol's structural characteristics.

Main Methods:

  • * Assessed natamycin's effect on isolated yeast vacuole fusion.
  • * Evaluated vacuole membrane barrier function in the presence of natamycin.
  • * Utilized yeast strains with altered ergosterol biosynthesis to test natamycin's specificity.
  • * Examined the impact of sublethal natamycin doses on cellular vacuole morphology.

Main Results:

  • * Natamycin blocked vacuole membrane fusion without compromising membrane integrity.
  • * Sublethal natamycin concentrations induced significant alterations in yeast vacuole morphology.
  • * Natamycin's inhibitory effect was dependent on specific structural features of ergosterol.
  • * Natamycin was found to inhibit the priming stage of vacuole fusion, similar to nystatin.

Conclusions:

  • * Natamycin exhibits a novel mechanism of action by inhibiting vacuole membrane fusion.
  • * This inhibition occurs at the ergosterol-dependent priming stage, preceding fusion.
  • * The findings suggest polyene antibiotics may broadly affect ergosterol-dependent protein functions.
  • * Natamycin's action provides new insights into the role of ergosterol in membrane dynamics.

More Related Videos

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

Native Cell Membrane Nanoparticles System for Membrane Protein-Protein Interaction Analysis07:31

Native Cell Membrane Nanoparticles System for Membrane Protein-Protein Interaction Analysis

Published on: July 16, 2020

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...